| dc.contributor.author | Shim, Joanna | |
| dc.contributor.author | Jones, Gareth T | |
| dc.contributor.author | Pathan, Ejaz M I | |
| dc.contributor.author | Macfarlane, Gary J | |
| dc.date.accessioned | 2018-11-02T16:40:09Z | |
| dc.date.available | 2018-11-02T16:40:09Z | |
| dc.date.issued | 2018-11-01 | |
| dc.identifier | 129697765 | |
| dc.identifier | 50882dc2-3cfc-463d-b4da-4fe3ef1cf07d | |
| dc.identifier | 85052302301 | |
| dc.identifier.citation | Shim , J , Jones , G T , Pathan , E M I & Macfarlane , G J 2018 , ' Impact of biological therapy on work outcomes in patients with axial spondyloarthritis : results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis ' , Annals of the Rheumatic Diseases , vol. 77 , no. 11 , pp. 1578-1584 . https://doi.org/10.1136/annrheumdis-2018-213590 | en |
| dc.identifier.issn | 0003-4967 | |
| dc.identifier.other | ORCID: /0000-0003-2322-3314/work/72631747 | |
| dc.identifier.other | ORCID: /0000-0003-0016-7591/work/83704081 | |
| dc.identifier.uri | http://hdl.handle.net/2164/11385 | |
| dc.description | Funding The BSRBR-AS is funded by the British Society for Rheumatology who have received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments. This work was conducted within the Arthritis Research UK/Medical Research Council Centre for Musculoskeletal Work and Health (Grant No: 20665) Acknowledgements We are grateful to the staff of the British Society for Rheumatology Biologics Register in Axial Spondyloarthritis register who are currently Claudia Zabke, Maureen Heddle, Nafeesa Nazlee and Barry Morris, and to the recruiting staff at the clinical centres, details of which are available at: https://www.abdn.ac.uk/iahs/research/epidemiology/spondyloarthritis.php#panel1011. We would like to thank Dr Atul Deodhar, Benjamin Hsu and Chenglong Han for providing additional data relating to one of the studies, to allow it be included in the meta-analysis. | en |
| dc.format.extent | 7 | |
| dc.format.extent | 883975 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Annals of the Rheumatic Diseases | en |
| dc.subject | R Medicine | en |
| dc.subject | Arthritis Research UK (ARUK) | en |
| dc.subject | 20665 | en |
| dc.subject | Medical Research Council (MRC) | en |
| dc.subject | 20665 | en |
| dc.subject.lcc | R | en |
| dc.title | Impact of biological therapy on work outcomes in patients with axial spondyloarthritis : results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Epidemiology Group | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH) | en |
| dc.contributor.institution | University of Aberdeen.Vice Principals | en |
| dc.description.status | Peer reviewed | en |
| dc.identifier.doi | 10.1136/annrheumdis-2018-213590 | |
